Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.

Da Silva T, Hafizi S, Watts JJ, Weickert CS, Meyer JH, Houle S, Rusjan P, Mizrahi R.

JAMA Psychiatry. 2019 Sep 18. doi: 10.1001/jamapsychiatry.2019.2516. [Epub ahead of print]

PMID:
31532458
2.

Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.

Schifani C, Hafizi S, Tseng HH, Gerritsen C, Kenk M, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Schizophr Res. 2018 Nov 5. pii: S0920-9964(18)30610-8. doi: 10.1016/j.schres.2018.10.008. [Epub ahead of print]

PMID:
30409695
3.

GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.

Da Silva T, Hafizi S, Rusjan PM, Houle S, Wilson AA, Prce I, Sailasuta N, Mizrahi R.

J Psychiatry Neurosci. 2019 Mar 1;44(2):111-119. doi: 10.1503/jpn.170201.

4.

Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.

Shakory S, Watts JJ, Hafizi S, Da Silva T, Khan S, Kiang M, Bagby RM, Chavez S, Mizrahi R.

Neuropsychopharmacology. 2018 Oct;43(11):2249-2255. doi: 10.1038/s41386-018-0163-0. Epub 2018 Jul 28.

5.

TSPO expression and brain structure in the psychosis spectrum.

Hafizi S, Guma E, Koppel A, Da Silva T, Kiang M, Houle S, Wilson AA, Rusjan PM, Chakravarty MM, Mizrahi R.

Brain Behav Immun. 2018 Nov;74:79-85. doi: 10.1016/j.bbi.2018.06.009. Epub 2018 Jun 12.

PMID:
29906515
6.

Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.

Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G, Prce I, Wilson AA, Rusjan PM, Sailasuta N, Mizrahi R.

Neuropsychopharmacology. 2018 Jul;43(8):1700-1705. doi: 10.1038/s41386-018-0061-5. Epub 2018 Apr 13.

7.

Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis.

Da Silva T, Hafizi S, Andreazza AC, Kiang M, Bagby RM, Navas E, Laksono I, Truong P, Gerritsen C, Prce I, Sailasuta N, Mizrahi R.

Int J Neuropsychopharmacol. 2018 Apr 1;21(4):311-318. doi: 10.1093/ijnp/pyx094.

8.

The effect of SPARK on social and motor skills of children with autism.

Najafabadi MG, Sheikh M, Hemayattalab R, Memari AH, Aderyani MR, Hafizi S.

Pediatr Neonatol. 2018 Oct;59(5):481-487. doi: 10.1016/j.pedneo.2017.12.005. Epub 2018 Jan 6.

9.

Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Schifani C, Hafizi S, Da Silva T, Watts JJ, Khan MS, Mizrahi R.

Int Rev Psychiatry. 2017 Dec;29(6):555-566. doi: 10.1080/09540261.2017.1396205. Epub 2017 Dec 8. Review.

PMID:
29219634
10.

Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment.

Knezevic D, Verhoeff NPL, Hafizi S, Strafella AP, Graff-Guerrero A, Rajji T, Pollock BG, Houle S, Rusjan PM, Mizrahi R.

J Cereb Blood Flow Metab. 2018 Nov;38(11):1885-1895. doi: 10.1177/0271678X17741395. Epub 2017 Nov 14.

PMID:
29135331
11.

Towards an Integrated View of Early Molecular Changes Underlying Vulnerability to Social Stress in Psychosis.

Barron H, Hafizi S, Mizrahi R.

Mod Trends Pharmacopsychiatry. 2017;31:96-106. doi: 10.1159/000470810. Epub 2017 Jul 24.

PMID:
28738349
12.

Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.

Hafizi S, Da Silva T, Gerritsen C, Kiang M, Bagby RM, Prce I, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Neuropsychopharmacology. 2017 Dec;42(13):2474-2481. doi: 10.1038/npp.2017.111. Epub 2017 Jun 12.

13.

TAM Receptor Tyrosine Kinases in Cancer Drug Resistance.

Vouri M, Hafizi S.

Cancer Res. 2017 Jun 1;77(11):2775-2778. doi: 10.1158/0008-5472.CAN-16-2675. Epub 2017 May 19. Review.

14.

The Persian Version of Örebro Musculoskeletal Pain Screening Questionnaire: Translation and Evaluation of its Psychometric Properties.

Sharafi SE, Hafizi S, Shahi MH, Kordi R, Noorbala AA, Arbabi M, Nejatisafa AA.

Int J Prev Med. 2017 Mar 7;8:14. doi: 10.4103/2008-7802.201658. eCollection 2017.

15.

Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk.

Barron H, Hafizi S, Andreazza AC, Mizrahi R.

Int J Mol Sci. 2017 Mar 17;18(3). pii: E651. doi: 10.3390/ijms18030651. Review.

16.

Early-Onset Friedreich's Ataxia With Oculomotor Apraxia.

Saghazadeh A, Hafizi S, Hosseini F, Ashrafi MR, Rezaei N.

Acta Med Iran. 2017 Feb;55(2):128-130.

17.

Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells.

Vouri M, Croucher DR, Kennedy SP, An Q, Pilkington GJ, Hafizi S.

Oncogenesis. 2016 Oct 24;5(10):e266. doi: 10.1038/oncsis.2016.66.

18.

Gas6 Promotes Oligodendrogenesis and Myelination in the Adult Central Nervous System and After Lysolecithin-Induced Demyelination.

Goudarzi S, Rivera A, Butt AM, Hafizi S.

ASN Neuro. 2016 Sep 14;8(5). pii: 1759091416668430. doi: 10.1177/1759091416668430. Print 2016 Oct.

19.

Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.

Hafizi S, Tseng HH, Rao N, Selvanathan T, Kenk M, Bazinet RP, Suridjan I, Wilson AA, Meyer JH, Remington G, Houle S, Rusjan PM, Mizrahi R.

Am J Psychiatry. 2017 Feb 1;174(2):118-124. doi: 10.1176/appi.ajp.2016.16020171. Epub 2016 Sep 9.

20.

Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.

Assar EA, Vidalle MC, Chopra M, Hafizi S.

Tumour Biol. 2016 Jul;37(7):9375-85. doi: 10.1007/s13277-016-4798-3. Epub 2016 Jan 16.

PMID:
26779636
21.

Hollow-layered nanoparticles for therapeutic delivery of peptide prepared using electrospraying.

Rasekh M, Young C, Roldo M, Lancien F, Le Mével JC, Hafizi S, Ahmad Z, Barbu E, Gorecki D.

J Mater Sci Mater Med. 2015 Nov;26(11):256. doi: 10.1007/s10856-015-5588-y. Epub 2015 Oct 8.

PMID:
26449446
22.

Depression and Exercise: A Clinical Review and Management Guideline.

Ranjbar E, Memari AH, Hafizi S, Shayestehfar M, Mirfazeli FS, Eshghi MA.

Asian J Sports Med. 2015 Jun;6(2):e24055. doi: 10.5812/asjsm.6(2)2015.24055. Epub 2015 Jun 20. Review.

23.

Inflammation in venous thromboembolism: Cause or consequence?

Saghazadeh A, Hafizi S, Rezaei N.

Int Immunopharmacol. 2015 Sep;28(1):655-65. doi: 10.1016/j.intimp.2015.07.044. Epub 2015 Aug 4. Review.

PMID:
26253657
24.

The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.

Sahakian BJ, Bruhl AB, Cook J, Killikelly C, Savulich G, Piercy T, Hafizi S, Perez J, Fernandez-Egea E, Suckling J, Jones PB.

Philos Trans R Soc Lond B Biol Sci. 2015 Sep 19;370(1677):20140214. doi: 10.1098/rstb.2014.0214. Review.

25.
26.

Serum levels of vascular endothelial growth factor in chronic obstructive pulmonary disease.

Farid Hosseini R, Jabbari Azad F, Yousefzadeh H, Rafatpanah H, Hafizi S, Tehrani H, Khani M.

Med J Islam Repub Iran. 2014 Aug 2;28:85. eCollection 2014.

27.

Borderline Personality Disorder and Religion: A perspective from a Muslim country.

Hafizi S, Tabatabaei D, Koenig HG.

Iran J Psychiatry. 2014 Jul;9(3):137-41.

28.

Addiction in iran: the need for culturally and religiously adapted preventive/ recovery programs.

Hafizi S.

Int J High Risk Behav Addict. 2013 Jun;2(1):46-7. doi: 10.5812/ijhrba.8003. Epub 2013 Jun 26. No abstract available.

29.

High frequency TMS for the management of Borderline Personality Disorder: a case report.

Arbabi M, Hafizi S, Ansari S, Oghabian MA, Hasani N.

Asian J Psychiatr. 2013 Dec;6(6):614-7. doi: 10.1016/j.ajp.2013.05.006. Epub 2013 Jun 14.

PMID:
24309885
30.

Sleep and borderline personality disorder: a review.

Hafizi S.

Asian J Psychiatr. 2013 Dec;6(6):452-9. doi: 10.1016/j.ajp.2013.06.016. Epub 2013 Jul 24. Review.

PMID:
24309854
31.

Functional characterisation of human cells harbouring a novel t(2p;7p) translocation involving TNS3 and EXOC6B genes.

Ludwig D, Carter J, Smith JR, Borsani G, Barlati S, Hafizi S.

BMC Med Genet. 2013 Jun 28;14:65. doi: 10.1186/1471-2350-14-65.

32.

CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.

Carter JA, Górecki DC, Mein CA, Ljungberg B, Hafizi S.

Epigenetics. 2013 Jul;8(7):739-47. doi: 10.4161/epi.25075. Epub 2013 May 24.

33.

Cross-cultural adaptation, reliability, and validity of the autism treatment evaluation checklist in persian.

Memari AH, Shayestehfar M, Mirfazeli FS, Rashidi T, Ghanouni P, Hafizi S.

Iran J Pediatr. 2013 Jun;23(3):269-75.

34.

Attitudes of Muslim physicians and nurses toward religious issues.

Hafizi S, Koenig HG, Arbabi M, Pakrah M, Saghazadeh A.

J Relig Health. 2014 Oct;53(5):1374-81. doi: 10.1007/s10943-013-9730-1.

PMID:
23690131
35.

The Duke University Religion Index (DUREL): validation and reliability of the Farsi version.

Hafizi S, Memari AH, Pakrah M, Mohebi F, Saghazadeh A, Koenig HG.

Psychol Rep. 2013 Feb;112(1):151-9.

PMID:
23654034
36.

Identification of candidate genes encoding an LDL-C QTL in baboons.

Karere GM, Glenn JP, Birnbaum S, Hafizi S, Rainwater DL, Mahaney MC, VandeBerg JL, Cox LA.

J Lipid Res. 2013 Jul;54(7):1776-85. doi: 10.1194/jlr.M032649. Epub 2013 Apr 17. Erratum in: J Lipid Res. 2013 Aug;54(8):2291. Hafizi, Sassan [added].

37.

Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.

Ammoun S, Provenzano L, Zhou L, Barczyk M, Evans K, Hilton DA, Hafizi S, Hanemann CO.

Oncogene. 2014 Jan 16;33(3):336-46. doi: 10.1038/onc.2012.587. Epub 2013 Jan 14.

PMID:
23318455
38.

Interaction of DISC1 with the PTB domain of Tensin2.

Goudarzi S, Smith LJ, Schütz S, Hafizi S.

Cell Mol Life Sci. 2013 May;70(9):1663-72. doi: 10.1007/s00018-012-1228-6. Epub 2012 Dec 12.

PMID:
23233134
39.

Physical activity in children and adolescents with autism assessed by triaxial accelerometry.

Memari AH, Ghaheri B, Ziaee V, Kordi R, Hafizi S, Moshayedi P.

Pediatr Obes. 2013 Apr;8(2):150-8. doi: 10.1111/j.2047-6310.2012.00101.x. Epub 2012 Oct 8.

PMID:
23042790
40.

Evidence for the differential co-localization of neurokinin-1 receptors with 5-HT receptor subtypes in rat forebrain.

Hafizi S, Serres F, Pei Q, Totterdell S, Sharp T.

J Psychopharmacol. 2012 Apr;26(4):505-15. doi: 10.1177/0269881111425969. Epub 2011 Nov 5.

PMID:
22057017
41.

Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.

Hafizi S, Gustafsson A, Oslakovic C, Idevall-Hagren O, Tengholm A, Sperandio O, Villoutreix BO, Dahlbäck B.

Biochem Biophys Res Commun. 2010 Aug 27;399(3):396-401. doi: 10.1016/j.bbrc.2010.07.085. Epub 2010 Aug 3.

PMID:
20678486
42.

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.

Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ.

Psychopharmacology (Berl). 2010 Jun;210(3):419-28. doi: 10.1007/s00213-010-1842-7. Epub 2010 Apr 20.

PMID:
20401747
43.

Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.

Hafizi S, Sernstad E, Swinny JD, Gomez MF, Dahlbäck B.

Int J Biochem Cell Biol. 2010 Jan;42(1):52-61. doi: 10.1016/j.biocel.2009.09.005. Epub 2009 Sep 9.

PMID:
19747564
44.

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.

Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ.

Psychopharmacology (Berl). 2009 Nov;207(1):133-42. doi: 10.1007/s00213-009-1641-1. Epub 2009 Aug 25.

PMID:
19705104
45.

Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.

Gustafsson A, Martuszewska D, Johansson M, Ekman C, Hafizi S, Ljungberg B, Dahlbäck B.

Clin Cancer Res. 2009 Jul 15;15(14):4742-9. doi: 10.1158/1078-0432.CCR-08-2514. Epub 2009 Jun 30.

46.

NK1 receptor antagonism and emotional processing in healthy volunteers.

Chandra P, Hafizi S, Massey-Chase RM, Goodwin GM, Cowen PJ, Harmer CJ.

J Psychopharmacol. 2010 Apr;24(4):481-7. doi: 10.1177/0269881109103101. Epub 2009 Apr 7.

PMID:
19351798
47.

Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.

Martuszewska D, Ljungberg B, Johansson M, Landberg G, Oslakovic C, Dahlbäck B, Hafizi S.

PLoS One. 2009;4(2):e4350. doi: 10.1371/journal.pone.0004350. Epub 2009 Feb 4.

48.

Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations.

Hafizi S, Chandra P, Cowen J.

Br J Psychiatry. 2007 Oct;191:282-4.

PMID:
17906236
49.

Interferon-induced depression: mechanisms and management.

Hafizi S, Favaron E.

Br J Hosp Med (Lond). 2007 Jun;68(6):307-10. Review. No abstract available.

PMID:
17639827
50.

Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.

Hafizi S, Dahlbäck B.

FEBS J. 2006 Dec;273(23):5231-44. Epub 2006 Oct 25. Review.

Supplemental Content

Loading ...
Support Center